Baird Maintains Neutral on Medpace Hldgs, Lowers Price Target to $313

Benzinga · 1d ago
Baird analyst Eric Coldwell maintains Medpace Hldgs (NASDAQ:
MEDP) with a Neutral and lowers the price target from $340 to $313.
Disclaimer:This article represents the opinion of the author only. It does not represent the opinion of Webull, nor should it be viewed as an indication that Webull either agrees with or confirms the truthfulness or accuracy of the information. It should not be considered as investment advice from Webull or anyone else, nor should it be used as the basis of any investment decision.